Pernix Commences Refinancing Transactions to Fortify Balance Sheet

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/18/2026

1. VRNS
2. CRWV
3. JBHT
4. TSLA
5. GPRK
6. SCHW
7. TRV
8. TFC
9. TECHM:IN
10. NVDA

Go back to Pernix Commences Refinancing Transactions to Fortify Balance Sheet

Pernix Therapeutics (PTX) Reports Prelim. Q2 Revenue of $33M-$35M

July 20, 2017 4:57 PM EDT

Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX) today announced certain preliminary unaudited financial results for the second quarter ended June 30, 2017.

Second Quarter 2017 Preliminary Unaudited Financial Highlights:

Second quarter 2017 net revenues are expected to be between $33.0 million and $35.0 million, which would represent a decrease of between 5% and 10% versus second quarter 2016 net revenues of $36.7 million.Second quarter 2017 selling, general and administrative expense is expected to be between $18.0... More